Foundry Partners, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$3,747,000
-10.2%
84,3250.0%0.23%
+6.1%
Q1 2022$4,173,000
+32.9%
84,325
+36.7%
0.21%
+91.9%
Q4 2021$3,140,000
-11.6%
61,665
-3.2%
0.11%
-12.6%
Q3 2021$3,552,000
+24.6%
63,685
-4.4%
0.13%
+29.6%
Q2 2021$2,850,000
-13.3%
66,585
-15.5%
0.10%
-9.3%
Q1 2021$3,288,000
-13.6%
78,771
-3.6%
0.11%
-27.5%
Q4 2020$3,804,000
+15.9%
81,676
+5.8%
0.15%
-6.3%
Q3 2020$3,281,000
-8.9%
77,231
+2.9%
0.16%
-9.7%
Q2 2020$3,602,000
-7.4%
75,073
-11.2%
0.18%
-19.6%
Q1 2020$3,891,000
-7.9%
84,577
+20.2%
0.22%
+37.7%
Q4 2019$4,227,000
-1.9%
70,357
-7.6%
0.16%
-10.7%
Q3 2019$4,308,000
+5.4%
76,160
+3.8%
0.18%
+10.6%
Q2 2019$4,086,000
+964.1%
73,385
+865.6%
0.16%
+973.3%
Q1 2019$384,000
-42.7%
7,600
-40.9%
0.02%
+7.1%
Q4 2018$670,000
+84.1%
12,850
+144.8%
0.01%0.0%
Q3 2018$364,000
-15.2%
5,250
-7.3%
0.01%
-22.2%
Q2 2018$429,000
+44.0%
5,6650.0%0.02%
+38.5%
Q1 2018$298,000
-23.8%
5,665
-22.6%
0.01%
-18.8%
Q4 2017$391,000
+74.6%
7,315
+95.1%
0.02%
+77.8%
Q3 2017$224,0003,7500.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders